Diabetes Research

Joslin's research team represents the most comprehensive and dynamic research program dedicated exclusively to diabetes anywhere in the world. More than 300 scientists are committed to pursuing innovative pathways of discovery to prevent, treat and cure type 1 and type 2 diabetes and their complications.

Selected Recent Research Findings

Type 1 diabetes
Prediction, prevention and detection; repair and restoration of insulin-producing beta cells; clinical trials of technologies and medications

Ultimate Diabetes Survivors, the Joslin 50-Year Medalists, Give Clues to Cures

Q&A | Gordon Weir on Type 1 Diabetes Research

Joslin Shows Transplanted Beta Cells Learn to Deal with Stress


Type 2 diabetes
Medications to combat insulin resistance; clinical trials of medications, technologies and lifestyle modifications

Generic Drug for Type 2 Diabetes Passes Next Clinical Hurdle

Clinical Trial Compares Leading-Edge Treatments for Obesity and Diabetes

The Trouble with Tribbles in Diabetes


Complications
Prediction, prevention and reversal of diabetes complications through eye, kidney, vascular cell and beta cell research

Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema

Joslin Research Shows Insulin Guards Against Artery Damage

 

Virtual Tour

Virtual tour of Joslin Diabetes Center featuring Joslin research and clinic leaders

We invite you to take a virtual tour of Joslin Diabetes Center and meet our leaders in basic research, clinical research and patient care for both adults and children.

Make a gift to support Joslin research

The generosity of individual donors ensures our ability to expand our existing research programs and launch cutting-edge initiatives.

If you would like to learn how your gift can support Joslin research, click here

Or contact the Joslin Development Office at (617) 732-2412.

Visit the Joslin Research Web Site

The Joslin research team maintains a web site for persons in the research community who would like to learn more about our work.